Michael Ha

Q: What is Michael Ha's success rate?

Michael Ha currently has a success rate of 97.86312014345488.

Q: What is the average return of Michael Ha's calls?

Their stock ratings have generated an average return of 7.11210607887032.

Baird | Healthcare

Michael Ha is an analyst from Baird specializing in the Healthcare sector. Ranked #1293 out of 4773 analysts, they have issued 19 stock ratings with a success rate of 97.86% and an average return of 7.11%.

With 19 ratings to date, Michael Ha is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 97.86% and an average return of 7.11%, highlighting promising potential as their track record develops further.

#1293

Out of 4773

Total Ratings

+97.86%

Success Rate

+7.11%

Average Return

Recent Ratings Analysis

UHS

Hold

Jul 29, 2026

Target

$166.00

Current

$174.83

Performance

3.97%

Michael Ha rated UHS as Neutral on Jul 29, 2026, setting a price target of 166. The Hold stance appears justified, as shares hovered around 174.83 with a 3.97% move.

CNC

Hold

Jul 29, 2026

Target

$66.00

Current

$66.40

Performance

7.41%

On Jul 29, 2026, CNC was given a Neutral rating by Michael Ha, with a target price of 66. The stock rallied from 66.4 to 66.4 after the Hold rating, surprising to the upside.

THC

Hold

Jul 28, 2026

Target

$280.00

Current

$263.69

Performance

0.40%

THC received a Neutral rating from Michael Ha on Jul 28, 2026, aiming for 280. Shares remained flat at 263.69, aligning with the neutral rating.

HCA

Hold

Jul 27, 2026

Target

$393.00

Current

$426.94

Performance

9.58%

On Jul 27, 2026, Michael Ha published a Neutral outlook on HCA, with a target of 393. The Hold call missed some of the bullish momentum as shares advanced toward 393.

ELV

Hold

Jul 16, 2026

Target

$393.00

Current

$418.72

Performance

12.30%

Michael Ha on Jul 16, 2026 assigned ELV a Neutral rating, with a price target of 393. Shares outperformed expectations, climbing 12.30% despite the neutral view.

UNH

Hold

Jul 16, 2026

Target

$453.00

Current

$379.09

Performance

-10.46%

On Jul 16, 2026, Michael Ha reaffirmed UNH with a Neutral rating, targeting 453. The Hold stance reflected market caution that was later justified.

MOH

Hold

May 11, 2026

Target

$163.00

Current

$204.23

Performance

10.28%

MOH was rated Neutral by Michael Ha on May 11, 2026, with a price objective of 163. Despite caution, upside momentum rewarded risk-takers with gains to 204.23.

OSCR

Hold

May 07, 2026

Target

$19.00

Current

$32.77

Performance

57.02%

On May 07, 2026, Michael Ha initiated coverage on OSCR with a Neutral rating and target of 19. The Hold stance underestimated the stock’s strength as it gained 57.02%.

CVS

Buy

Apr 15, 2026

Target

$94.00

Current

$94.66

Performance

—

Michael Ha issued a Outperform recommendation for CVS on Apr 15, 2026, price target set at 94. The target of 94 remains in play, though confirmation will depend on future moves.

ASTH

Buy

Apr 15, 2026

Target

$40.00

Current

$37.98

Performance

—

On Apr 15, 2026, ASTH was evaluated by Michael Ha, who gave a Outperform rating and target of 40. So far, the Buy call awaits clearer momentum, with shares flat at 37.98.

CI

Buy

Aug 14, 2025

Target

$374.00

Current

$280.76

Performance

-3.30%

Michael Ha rated CI as Outperform on Aug 14, 2025, setting a price target of 374. Shares have remained stable near 280.76, leaving the 374 target still in play.

HUM

Hold

Jul 25, 2025

Target

$297.00

Current

$409.85

Performance

72.22%

On Jul 25, 2025, HUM was given a Neutral rating by Michael Ha, with a target price of 297. The stock rallied from 409.85 to 409.85 after the Hold rating, surprising to the upside.

PRVA

Buy

Aug 26, 2024

Target

$24.00

Current

$20.42

Performance

-4.09%

PRVA received a Outperform rating from Michael Ha on Aug 26, 2024, aiming for 24. Price action was muted, as shares hovered around 20.42 despite the bullish outlook.

ALHC

Buy

Aug 14, 2024

Target

$11.00

Current

$12.61

Performance

45.44%

On Aug 14, 2024, Michael Ha published a Outperform outlook on ALHC, with a target of 11. Shares gained 45.44%, underscoring the accuracy of the bullish outlook toward 11.

Frequency Asked Questions

Who is Michael Ha?

Michael Ha is an analyst from Baird specializing in the Healthcare sector.

What is Michael Ha's success rate?

Michael Ha currently has a success rate of +97.86%.

How many ratings has Michael Ha issued?

Michael Ha has issued 19 stock ratings so far.

What is the average return of Michael Ha's calls?

Their stock ratings have generated an average return of +7.11%.

What is Michael Ha's ranking?

Michael Ha is ranked #1293 out of 4773 analysts.

What types of ratings does Michael Ha give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Michael Ha?

You can follow Michael Ha by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Michael Ha?

Their latest rating was a Hold on UHS issued on 2026-07-29.